Vident Advisory’s Xylem XYL Stock Holding History

Vident Advisory’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Sell	8,726 -21,574	-71%	-$2.49M	0.01%	954
2026 Q1	$3.62M	Buy	30,300 +20,537	+210%	+$2.69M	0.03%	442
2025 Q4	$1.33M	Sell	9,763 -98	-1%	-$14.1K	0.01%	706
2025 Q3	$1.45M	Buy	9,861 +3,865	+64%	+$536K	0.01%	673
2025 Q2	$776K	Buy	5,996 +674	+13%	+$81.6K	0.01%	843
2025 Q1	$636K	Buy	5,322 +1,979	+59%	+$245K	0.01%	903
2024 Q4	$388K	Sell	3,343 -10,713	-76%	-$1.35M	0.01%	1069
2024 Q3	$1.9M	Buy	14,056 +9,684	+222%	+$1.3M	0.05%	402
2024 Q2	$593K	Sell	4,372 -2,486	-36%	-$338K	0.02%	797
2024 Q1	$886K	Sell	6,858 -1,683	-20%	-$203K	0.02%	617
2023 Q4	$977K	Sell	8,541 -355	-4%	-$35.4K	0.02%	564
2023 Q3	$810K	Buy	+8,896	New	+$918K	0.03%	569

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Vident Advisory's XYL Position: Q2 2026 in Review

Vident Advisory reduced its Xylem (XYL) stake by 71% in Q2 2026, selling an estimated $2.49M and leaving 8,726 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #954.

Vident Advisory first reported a position in XYL in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.62M in Q1 2026. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Vident Advisory held 8,726 shares of Xylem worth $1.03M as of Q2 2026.
Vident Advisory sold 21,574 Xylem shares in Q2 2026, an estimated $2.49M.
Xylem made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #954 holding.
Vident Advisory first reported a position in Xylem in Q3 2023 and has held it in 12 quarters since.
Vident Advisory's Xylem position peaked at $3.62M in Q1 2026.
1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.